Please provide your email address to receive an email when new articles are posted on . A next-generation transcatheter aortic valve replacement system was associated with less hemodynamically ...

Please provide your email address to receive an email when new articles are posted on . A novel TAVR system was safe and effective for adults with severe aortic regurgitation who are not surgical ...

Patients who have both aortic stenosis and some degree of aortic regurgitation, so-called mixed aortic valve disease (MAVD), appear to have better survival after TAVR than those with pure aortic ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve replacement (TAVR) is currently a widely used option for patients with severe ...

SAN FRANCISCO -- Tip-top technique was important for longer-term survival after transcatheter aortic valve replacement (TAVR), a procedure that was also shown to give patients better health status ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

The FDA has given thumbs up to two clinical studies for a transcatheter aortic valve replacement (TAVR) system developed by HLT Inc. to treat aortic stenosis among high-risk patients. Those studies ...

The Federal Trade Commission (FTC) recently announced its intention to block Edwards Lifesciences’ acquisition of JenaValve, a medical device company focusing on transcatheter aortic valve replacement ...

March 26, 2012 (Chicago, Illinois) — Paravalvular leaks--a phenomenon virtually unheard of in the surgical valve replacement era--have truly been propelled into the limelight today, with the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...